Interest Area | Association of Corporate Counsel (ACC)

Featured Resources

Sample Forms, Policies, and Contracts

Due Diligence Checklist (Nonprofit Health Care Acquisition)

This comprehensive checklist identifies information for the due diligence process in connection with a proposed transaction between two parties. The entity responsible for producing requested documents should not have to create new documents. Production requests may seem duplicative; however, this is intentional in an effort to capture all relevant materials.
Sample Forms, Policies, and Contracts

HIPAA Security Assessment

This is a sample HIPAA security assessment.
Articles

Top Ten Considerations for Employers in States with Medical or Otherwise Legal Marijuana (US)

This Top Ten article addresses considerations for employers in states with medical or otherwise legal marijuana in the US.

Most Recent Resources

Articles

Comparing Supplementary Protection Regimes Between Canada (CSPs) and The EU (SPCs)

Nancy P. Pei, Partner, Smart & Biggar LLP, and Daniel Wise, Carpmaels & Ransford LLP

Tue, 09/19/2023 - 07:59

4 pages

Amendments to the Canadian Patent Act and enactment of the Certificate of Supplementary Protection Regulations flowing from the Canada-European Union (EU) Comprehensive Economic and Trade Agreement introduced a new framework in Canada for the issuance of Certificates of Supplementary Protection (CSPs).

This chart compare key aspects of the two regimes, Canada's and the EU's.

Resource Details

Interest Area: Intellectual Property, Health Law

Region: Canada, European Union

Audience: Deputy GC, Mid-Career, Small Law Departments, Large Law Departments

Download Save to My Resources
Not an ACC Member? Request a trial membership.

Articles

Canada's New Linkage Litigation Scheme: A Comparison to Hatch-Waxman

Nancy Pei, Partner, Smart & Biggar LLP and Brian Coggio, Fish & Richardson PC

Tue, 09/19/2023 - 07:53

5 pages

The September 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations introduced a new scheme for pharmaceutical patent linkage litigation in Canada. That scheme is now much closer to the United States' (US) Hatch-Waxman scheme, but with remaining key differences that are explained in this chart.

Resource Details

Interest Area: Intellectual Property, Health Law

Region: Canada, United States

Audience: Deputy GC, Mid-Career, Small Law Departments, Large Law Departments

Download Save to My Resources
Not an ACC Member? Request a trial membership.

Articles

Top 10 Patent and Regulatory Things You Need to Know when Bringing a Biopharma Product to Canada

Nancy Pei, Principal, Alice Tseng, Principal, Toronto Office and Daphne Lainson, Principal, Ottawa Office, Smart & Biggar LLP

Tue, 09/19/2023 - 07:20

Canada is an attractive market for pharmaceutical manufacturers. Most Canadian consumers have some form of drug coverage through government programs and/or private insurance. Below are ten patent and regulatory topics that in-house counsel need to know before bringing an innovative product to Canada.

Editor's note: This article was updated to reflect recent developments; the original version of this article was published on December 16, 2020.

Resource Details

Interest Area: Intellectual Property, Health Law

Region: Canada

Audience: Deputy GC, Mid-Career, Small Law Departments, Large Law Departments
Search the Resource Library

Search

Health Law